Table 2.

Baseline characteristics of patients in the study

Characteristics	Patients in benign group (n = 53)	Malignant patient (n = 1)	P-value
Age (in years)	44 (9)	57	0.039#
Male: Female	4:5	Male
BMI (kg/m2)	24.7(6)	28.4	0.526
Diabetes	8	1	0.121
Hypertension	6	NA
Hb (gm/dL)	10.4 (2.3)	11.6	0.483
White blood cells (cells/mm3)	8,340 (2,100)	9,400	0.394
Serum albumin (gm/dL)	3.2 (0.7)	3.8	0.292
ALT (U/L)	33 (24)	37	0.584
Total bilirubin (mg/dL)	0.92 (0.23)	0.71	0.476
GGT (U/L)	26 (20)	32	0.328
CA19-9 (u/mL)	3.2 (2)	2.09	0.162

Notes:

^#statistically significant;

GGT = gamma-glutamyl transferase; Hb = haemoglobin; Fisher’s exact test has been used comparative; BMI = body mass index